These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 20225034

  • 1. New protocol for lentiviral vector mass production.
    Segura MM, Garnier A, Durocher Y, Ansorge S, Kamen A.
    Methods Mol Biol; 2010; 614():39-52. PubMed ID: 20225034
    [Abstract] [Full Text] [Related]

  • 2. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A.
    Biotechnol Bioeng; 2007 Nov 01; 98(4):789-99. PubMed ID: 17461423
    [Abstract] [Full Text] [Related]

  • 3. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
    Kuroda H, Kutner RH, Bazan NG, Reiser J.
    J Virol Methods; 2009 May 01; 157(2):113-21. PubMed ID: 19114057
    [Abstract] [Full Text] [Related]

  • 4. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S, Lanthier S, Transfiguracion J, Durocher Y, Henry O, Kamen A.
    J Gene Med; 2009 Oct 01; 11(10):868-76. PubMed ID: 19618482
    [Abstract] [Full Text] [Related]

  • 5. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
    Lesch HP, Laitinen A, Peixoto C, Vicente T, Makkonen KE, Laitinen L, Pikkarainen JT, Samaranayake H, Alves PM, Carrondo MJ, Ylä-Herttuala S, Airenne KJ.
    Gene Ther; 2011 Jun 01; 18(6):531-8. PubMed ID: 21248790
    [Abstract] [Full Text] [Related]

  • 6. Optimized production and concentration of lentiviral vectors containing large inserts.
    al Yacoub N, Romanowska M, Haritonova N, Foerster J.
    J Gene Med; 2007 Jul 01; 9(7):579-84. PubMed ID: 17533614
    [Abstract] [Full Text] [Related]

  • 7. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
    Zhang B, Xia HQ, Cleghorn G, Gobe G, West M, Wei MQ.
    Gene Ther; 2001 Nov 01; 8(22):1745-51. PubMed ID: 11892843
    [Abstract] [Full Text] [Related]

  • 8. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
    Dormond E, Meneses-Acosta A, Jacob D, Durocher Y, Gilbert R, Perrier M, Kamen A.
    Biotechnol Bioeng; 2009 Feb 15; 102(3):800-10. PubMed ID: 18821637
    [Abstract] [Full Text] [Related]

  • 9. Transient gene expression in suspension HEK-293 cells: application to large-scale protein production.
    Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, Derow E, Wurm FM.
    Biotechnol Prog; 2005 Feb 15; 21(1):148-53. PubMed ID: 15903252
    [Abstract] [Full Text] [Related]

  • 10. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM, Kamen A, Garnier A.
    Methods Mol Biol; 2008 Feb 15; 434():1-11. PubMed ID: 18470635
    [Abstract] [Full Text] [Related]

  • 11. Polyethylenimine-based transfection method as a simple and effective way to produce recombinant lentiviral vectors.
    Toledo JR, Prieto Y, Oramas N, Sánchez O.
    Appl Biochem Biotechnol; 2009 Jun 15; 157(3):538-44. PubMed ID: 19089654
    [Abstract] [Full Text] [Related]

  • 12. Optimized large-scale production of high titer lentivirus vector pseudotypes.
    Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW.
    J Virol Methods; 2004 Dec 15; 122(2):131-9. PubMed ID: 15542136
    [Abstract] [Full Text] [Related]

  • 13. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
    Schambach A, Galla M, Modlich U, Will E, Chandra S, Reeves L, Colbert M, Williams DA, von Kalle C, Baum C.
    Exp Hematol; 2006 May 15; 34(5):588-92. PubMed ID: 16647564
    [Abstract] [Full Text] [Related]

  • 14. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.
    J Gene Med; 2005 Jun 15; 7(6):818-34. PubMed ID: 15693055
    [Abstract] [Full Text] [Related]

  • 15. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K.
    Gene Ther; 2002 Sep 15; 9(17):1155-62. PubMed ID: 12170379
    [Abstract] [Full Text] [Related]

  • 16. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
    Haas DL, Case SS, Crooks GM, Kohn DB.
    Mol Ther; 2000 Jul 15; 2(1):71-80. PubMed ID: 10899830
    [Abstract] [Full Text] [Related]

  • 17. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y, Pham PL, St-Laurent G, Jacob D, Cass B, Chahal P, Lau CJ, Nalbantoglu J, Kamen A.
    J Virol Methods; 2007 Sep 15; 144(1-2):32-40. PubMed ID: 17467815
    [Abstract] [Full Text] [Related]

  • 18. Production of lentiviral vectors in protein-free media.
    Kuroda H, Marino MP, Kutner RH, Reiser J.
    Curr Protoc Cell Biol; 2011 Mar 15; Chapter 26():Unit 26.8. PubMed ID: 21400699
    [Abstract] [Full Text] [Related]

  • 19. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
    Farson D, Harding TC, Tao L, Liu J, Powell S, Vimal V, Yendluri S, Koprivnikar K, Ho K, Twitty C, Husak P, Lin A, Snyder RO, Donahue BA.
    J Gene Med; 2004 Dec 15; 6(12):1369-81. PubMed ID: 15538729
    [Abstract] [Full Text] [Related]

  • 20. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
    Kuate S, Stefanou D, Hoffmann D, Wildner O, Uberla K.
    J Gene Med; 2004 Nov 15; 6(11):1197-205. PubMed ID: 15459964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.